Detection of Drug Resistance Gene in Cutaneous Leishmaniasis by PCR in Some Endemic Areas of Iran

AUTHORS

R Alizadeh 1 , H Hooshyar 2 , * , M Bandehpor 3 , M Arbabi 1 , F Kazemi 1 , A Talari 1 , B Kazemi 3

1 Department of Parasitology, School of Medicine, Kashan University of Medical Sciences, Iran

2 Department of Parasitology, School of Medicine, Kashan University of Medical Sciences, [email protected], Iran

3 Cellular and Molecular Biology Research Center, Shaheed Beheshti University of Medical Sciences, Iran

How to Cite: Alizadeh R, Hooshyar H, Bandehpor M, Arbabi M, Kazemi F, et al. Detection of Drug Resistance Gene in Cutaneous Leishmaniasis by PCR in Some Endemic Areas of Iran, Iran Red Crescent Med J. Online ahead of Print ; 13(12):863-867.

ARTICLE INFORMATION

Iranian Red Crescent Medical Journal: 13 (12); 863-867
Article Type: Research Article
Received: June 12, 2011
Accepted: September 19, 2011

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: Cutaneous leishmaniasis is still a health problem in many rural and urban regions of Iran and drug resistance has emerged as a major impediment in the treatment of leishmaniasis. This study aims to determine the drug resistance gene in cutaneous leishmaniasis by PCR in some endemic areas of Iran.

 

Methods: Ninety seven samples were collected from ulcers of leishmaniasis patients from some endemic areas of Iran. The Giemsa stained samples were examined microscopically and cultured in NNN and RPMI 1640 mediums for parasite detection. After DNA extraction, PCR was done by a pair of specific primers. For detection of mutation in DNA, first PCR products were electrophoresed on CSGE gel. The suspected samples were compared by sequencing and RFLP results were demonstrated. Comparison of DNA derived from a wild type cell and mutant cell was undertaken by CSGE and sequencing methods.

 

Results: Among 90 isolates (92.8%) examined for detection of mutation in gene with CSGE and RFLP, 10 (11.1%) revealed a disorder in sequencing selection for unresponsive to drug.

 

Conclusion: Drug resistance in cutaneous leishmaniasis to sodium stiboglocanat is probably due to a mutation in a genome. A field study is needed to determine the distribution of drug resistance and other gene mutations involved in unresponsiveness to drugs in leishmaniasis endemic areas of Iran.

Keywords

Cutaneous Leishmaniasis Drug resistance PCR Iran

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: